SEC Tracker
Get the app

Priveterra Acquisition AEON

As described below under Item 5.07 of this Current Report on Form 8-K, on July 3, 2023

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Reports an executive or board change (5.02)
  • Reports shareholder vote results (5.07)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Priveterra Acquisition files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. GT Biopharma GTBP public float $9M, Jun 30, 2025
  2. Biovie BIVI public float $8M, Dec 31, 2025
  3. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  4. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
  5. Talphera TLPH public float $8M, Jun 30, 2025